内类大麻素系统:在中枢神经系统疾病中药理学目标和治疗潜力
Laith N Al-Eitan1, Mohammad T ElSharkawy1, Saif Z Alahmad1
1Department of Biotechnology and Genetic Engineering, Jordan University of Science and Technology, Irbid 22110, Jordan.
Current neuropharmacology
|November 3, 2025
概括
内激素系统 (ECS) 影响大脑功能和神经系统疾病. 研究表明,针对ECS的疗法对治疗抑郁症,焦虑症和帕金森病等疾病具有前景.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 内分离系统 (ECS) 调节关键的大脑功能,包括突触传输,神经可塑性,情绪和免疫反应.
- 大麻素受体,特别是CB1和CB2,是神经生理和病理生理过程的核心.
- 欧洲神经系统与神经和精神疾病的发展有关.
研究的目的:
- 审查最近关于ECS在中枢神经系统疾病中的作用的发现.
- 检查大麻素受体药理学和实验技术的进展.
- 为ECS向策略的治疗潜力提供最新的视角.
主要方法:
- 对2015年至2025年间发表的研究的文献综述.
- 对包括抑郁症,焦虑症,疼痛,多发性硬化症和帕金森病在内的疾病研究的分析.
- 检查新的实验技术,如冷电磁,光遗传学和化学遗传学.
主要成果:
- 欧洲神经系统在各种神经和精神疾病的病理生理学中发挥着重要作用.
- 最近的技术进步加强了对大麻素受体的研究.
- 针对ECS的治疗方法显示出潜力,但在临床应用中面临挑战.
结论:
- 欧洲神经系统是治疗中枢神经系统疾病的有希望的目标.
- 需要进一步的研究来优化基于ECS的疗法的剂量和临床整合.
- 预计针对ECS的策略将在管理大脑健康方面变得越来越重要.
相关概念视频
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
758
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
758
Targets for Drug Action: Overview
10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Analgesia and Pain Management
1.5K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.5K
G Protein-coupled Receptors
16.4K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
16.4K
Opioid Receptors: Overview
4.0K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.0K
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
658
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
658


